Translate page

The importance of Molecular Monitoring in CML

Susan Branford, University of Adelaide, Australia

Please click on the image below to watch the webcast, and a window will open. You can then also click on the slides to jump to certain sections of the presentation. Please share your feedback below, and view the other Virtual Education Program modules.

 

webcast-button
vep branford molecmonitoring

 

Issues covered

  • Measurement of BCR-ABL transcript levels to assess residual disease
  • Recommended monitoring for CML
  • The significance of achieving a major molecular response

Has this been helpful? Please provide your comments here:

Facteur de variabilité de la réponse au ITK</li>
              <li>Les trois grand mécanismes de résistance</li>
              <li>La réponse au traitement</li>
              <li>Autres inhibiteurs de tyrosine kinase: le Nilotinib et le Dasatinib

Harlinda Haroen Community Builder Avatar   26.12.2011 (15:33:24)
Measurement of BCR-ABL Yes No Its a very valuable information, with an excellent presentation
 
ugroseno yudho Community Builder Avatar   20.12.2011 (01:22:19)
molecular monitoring Yes No molecular monitoring is very important to evaluate the respon of CML patient. but why must be examination every 3 month not more than 3 month?what happen with the bcr-abl if evaluation will be delayed until 6 month.
 
Amisa Mukaj Community Builder Avatar   15.12.2011 (18:11:42)
CML Yes No Brilliant presentation and very useful data regarding the importance of molecular monitoring